Contrast-Enhanced Ultrasound Evaluation of Canine Prostatic Hyperplasia Before and After Osaterone Acetate Therapy: Preliminary Results

    June 2024 in “ Animals
    Giorgia Pettina, Roberta Bucci, Antonio Mazzetti, Marco Quartuccio, Domenico Robbe, Maria Carmela Pisu
    Studysummary This study found that treating dogs with benign prostatic hyperplasia using osaterone acetate reduced prostatic volume and increased diffusion times of an ultrasound contrast agent, suggesting effective treatment and potential for CEUS monitoring.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →